Effect of TachoSil Patch in Prevention of Postoperative Pancreatic Fistula
| Autor: | Airazat M. Kazaryan, Irina Pavlik Marangos, Arne R. Rosseland, Bjørn Edwin, Bård I. Røsok |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male medicine.medical_specialty Pancreas resection Adolescent medicine.medical_treatment Treatment outcome TachoSil Pancreatic Fistula Young Adult Pancreatectomy medicine Humans Laparoscopy Severe complication Aged Retrospective Studies Aged 80 and over medicine.diagnostic_test business.industry Thrombin Gastroenterology Fibrinogen Postoperative complication Retrospective cohort study Length of Stay Middle Aged medicine.disease Surgery Drug Combinations Treatment Outcome Pancreatic fistula Original Article Female business |
| Zdroj: | Journal of Gastrointestinal Surgery |
| ISSN: | 1873-4626 1091-255X |
| DOI: | 10.1007/s11605-011-1584-9 |
| Popis: | Background Postoperative pancreatic fistula (POPF) is a severe complication after pancreatic resections. The aim was to assess if application of TachoSil® patch could reduce incidence of postoperative fistulas after laparoscopic distal pancreatic resections. Methods This is a retrospective study of prospectively collected data after enucleations and distal pancreatic resections. Patients were divided in two groups: with or without application of TachoSil® patch. Demographic and surgical data were analyzed. Results One hundred twenty-one patients with distal pancreatic resections without additional resections were identified among 230 patients operated by laparoscopic approach at our institution since 1998. They were divided into two groups. In group 1 (n = 48), TachoSil® patch was not applied while in group 2 (n = 73), the pancreatic stump was covered with TachoSil®. Postoperative fistulas were registered in 8% (4/48) and 12% (9/73) in groups 1 and 2, respectively. The median duration of postoperative hospital stay in group 1 was 5.5 (2–35) days compared with 5 (2–16) days in group 2. No significant difference in surgical outcomes was found. Conclusions The application of the TachoSil® patch did not affect either occurrence of POPF or duration of postoperative hospital stay. Routine use of TachoSil® patch to prevent pancreatic fistulas does not provide clinically significant benefit. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink